(:IGAP)

Mar 14, 2022 09:15 am ET
GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change
GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), formerly known as Integrity Applications, Inc., (Nasdaq: IGAP), innovator of GlucoTrack®, a non-invasive device and digital health platform for measuring glucose levels in people with...
Dec 20, 2021 11:57 am ET
Integrity Applications Issues Shareholder Update Letter
Integrity Applications, Inc. (www.integrity-app.com) (NASDAQ: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type II diabetes and prediabetes announced today that Paul V. Goode, PhD, President...
Dec 08, 2021 08:30 am ET
Integrity Applications Announces Uplisting to Nasdaq Capital Market
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that its shares of common stock were...
Dec 06, 2021 09:36 am ET
Integrity Applications, Inc. Expands U.S. Operations with the hiring of James P. Thrower, PhD, as Vice President of Engineering
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that James P. Thrower, PhD, has joined...
Nov 29, 2021 08:30 am ET
Integrity Applications Announces Name Change to GlucoTrack, Inc.
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today the change of its corporate name to...
Oct 21, 2021 10:00 am ET
Integrity Applications Announces the Appointment of Paul V. Goode, PhD, as President and Chief Operating Officer
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that Paul V. Goode has been appointed...
Sep 20, 2021 04:06 pm ET
Integrity Applications, Inc. Announces Filing of Form S-3 Shelf Registration Statement
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has filed a universal shelf...
Aug 12, 2021 09:15 am ET
Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has implemented a 1-for-13...
Jun 22, 2021 09:00 am ET
Integrity Applications Appoints Luis J. Malavé to Board of Directors
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that Luis J. Malavé has been appointed...
Apr 21, 2021 10:05 am ET
Integrity Applications Announces the Appointment of David C. Klonoff, MD as Chair of Scientific Advisory Board
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has appointed David C. Klonoff,...
Feb 18, 2021 09:30 am ET
Integrity Applications Issues Shareholder Update Letter
Integrity Applications, Inc. (www.integrity-app.com) (IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, issued a letter to its shareholders providing an update on its...
Feb 02, 2021 09:00 am ET
Integrity Applications Announces the Promotion of Erez Ben-Zvi to General Manager
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has promoted Erez Ben-Zvi to...
Dec 17, 2020 09:15 am ET
Integrity Applications Appoints Paul V. Goode, PhD, to Board of Directors
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that Paul V. Goode has been appointed...
Nov 05, 2020 09:00 am ET
Integrity Applications Names Shalom Shushan as Chief Technology Officer
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that Shalom Shushan has joined the...
Sep 14, 2020 09:00 am ET
Integrity Applications Provides Commercial Update
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, today provided an update as to its commercialization...
Jul 13, 2020 09:00 am ET
Integrity Applications Expands and Strengthens Team with Appointment of Erez Ben-Zvi as Vice President of Product
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that Erez Ben-Zvi has joined the...
Apr 22, 2020 09:00 am ET
Integrity Applications Announces the Appointment of Yair Briman as Senior Executive Advisor
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that Yair Briman has joined the Company...
Apr 14, 2020 04:45 pm ET
Integrity Applications Issues Shareholder Update Letter
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, issued a letter to its shareholders providing an update...
Feb 24, 2020 09:00 am ET
Integrity Applications Announces Closing of $15.0 Million Private Placement
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has closed a private placement...
Jan 21, 2020 09:00 am ET
Integrity Applications Receives CE Mark Approval for Self-Calibration Version of its GlucoTrack® Non-Invasive Glucose Monitoring Device
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has received CE Mark approval...
Nov 20, 2019 09:00 am ET
Integrity Applications Announces the Appointment of David Malka as President
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today the appointment of David Malka as...
Nov 04, 2019 09:15 am ET
Integrity Applications Announces the Appointment of Allen E. Danzig to its Board of Directors and as Chair of the Nominating, Governance and Compensation Committee
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today the appointment of Allen E. Danzig to...
May 16, 2019 09:15 am ET
Integrity Applications Announces the Appointment of Robert T. Guest as Senior Advisor Industry Executive to Advise on Global Commercial Strategy
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that Robert T. Guest has joined the...
Dec 17, 2018 09:15 am ET
Integrity Applications Announces GlucoTrack® Customer Experience Program in the Netherlands
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that the Company has launched a...
Dec 07, 2018 09:15 am ET
Integrity Applications Announces GlucoTrack® Product Milestones
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that the Company has achieved several...
Oct 09, 2018 04:15 pm ET
Integrity Applications Announces Executive Leadership Changes
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, today announced that John Graham has resigned as chief...
Aug 14, 2018 09:15 am ET
Integrity Applications Receives First Order from CuraTec Nordic for GlucoTrack®
Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has received its first order from CuraTec Nordic...
Jul 25, 2018 09:15 am ET
Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Glucose Monitoring Device in the Nordic Countries
Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP) (“Integrity” or “Integrity Applications”) announced today that it has entered into an exclusive distribution agreement with CuraTec Nordic, a Scandinavian medical device...
Dec 28, 2017 08:30 am ET
Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Non-Invasive Glucose Monitoring Device in the Netherlands
WILMINGTON, Del. and ASHDOD, Israel, Dec. 28, 2017 /PRNewswire/ -- Integrity Applications, Inc. ("Integrity") (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has entered into an exclusive distribution agreement with MediReva B.V. for the GlucoTrack® in the Netherlands. According to the International Diabetes Federation, as of 2017, there are an estimated number of 970,000 adults living with diabetes in the Netherlands, representing approximately 5.7% of the adult population. T
Nov 01, 2017 05:15 pm ET
Integrity Applications Announces Re-Order of GlucoTrack® Devices
WILMINGTON, Del. and ASHDOD, Israel, Nov. 1, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP) ("Integrity" or the "Company"), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced that it has received the largest single re-order of GlucoTrack® to date. The recent order of GlucoTrack®, in the amount of US$460,000, was a re-order from an existing customer and represents a nearly two-fold increase from the original order. The purchase order was paid in full in advance of delivery, which is expected
Oct 23, 2017 09:15 am ET
Integrity Applications Announces Strategic Corporate Update
Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes, announced a strategic corporate update addressing the commercialization of GlucoTrack in the EU as well as outlining steps for an FDA approval in the U.S. and next-generation device capabilities. With the appointment of a new CEO in March 2017, and following a strategic review of resources, the company will be focusing on three key initiatives:
Sep 07, 2017 10:40 am ET
A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes
WILMINGTON, Del. and ASHDOD, Israel, Sept. 7, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, presents Data Demonstrating that the performance of GlucoTrack is comparable among patients with prediabetes, newly diagnosed type 2 diabetes and long duration of type 2 diabetes, at the 53rd EASD Annual Meeting in Lisbon, Portugal.
Sep 05, 2017 10:15 am ET
GlucoTrack® presents an innovation in type 2 diabetes management at the upcoming EASD in Lisbon, Portugal
WILMINGTON, Del. and ASHDOD, Israel, Sept. 5, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, announced today that it will be attending the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal, September 11th to September 15th.
Aug 02, 2017 10:15 am ET
Integrity Applications Announces Close of $12 Million Private Placement
WILMINGTON, Del. and ASHDOD, Israel, Aug. 2, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has successfully closed a private placement offering, raising approximately $12 million over the past 16 months. Accredited investors purchased units consisting of one share of Series C preferred stock, convertible into shares of the Company's common stock at $4.50 per share, and two warrants to purchase shares of the Company's common stock
Jun 12, 2017 09:00 am ET
Integrity Applications Presents Data Demonstrating that the Accuracy of GlucoTrack® Is Independent of Medication Regime at American Diabetes Association's 77th Scientific Sessions
WILMINGTON, Del. and ASHDOD, Israel, June 12, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and prediabetes, announced new data demonstrating the clinical performance of GlucoTrack, further supporting its suitability for people with type 2 diabetes across various medication regimes. The data were recently presented at the American Diabetes Association's (ADA) 77th Scientific Sessions in San Diego, CA. 
Jun 08, 2017 09:00 am ET
Integrity Applications, GlucoTrack® Innovator, Names David Podwalski as Chief Commercial Officer
WILMINGTON, Del. and ASHDOD, Israel, June 8, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and prediabetes, today announced the appointment of David Podwalski as Chief Commercial Officer.
May 25, 2017 09:00 am ET
Integrity Applications, GlucoTrack® Innovator, Expands Board of Directors with the Appointment of Michael Hauck
WILMINGTON, Del. and ASHDOD, Israel, May 25, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with type 2 diabetes and prediabetes, today announced the appointment of Michael Hauck to its Board of Directors.
May 23, 2017 09:00 am ET
Integrity Applications to Present GlucoTrack® Data at American Diabetes Association's 77th Scientific Sessions
WILMINGTON, Del. and ASHDOD, Israel, May 23, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with type 2 diabetes and prediabetes, today announced that the results of a study evaluating the influence of medications on the accuracy of GlucoTrack® will be presented at the American Diabetes Association's (ADA) 77th Scientific Sessions, June 9-13, 2017, in San Diego, CA.
Apr 13, 2017 05:15 pm ET
Integrity Applications Board Appoints Avner Gal as Chairman Emeritus and Scientific Advisor
ASHDOD, Israel, April 13, 2017 /PRNewswire/ -- The Board of Directors of Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it has appointed Avner Gal as Chairman Emeritus. Mr. Gal co-founded Integrity Applications and served as the company's CEO, Chairman of the Board and a director for 16 years. Mr. Gal is also joining Integrity's Scientific Advisory Board and will continue to work with the company in a part-time consulting role.
Mar 27, 2017 10:25 am ET
Integrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman
ASHDOD, Israel, March 27, 2017 /PRNewswire/ -- The Board of Directors of Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it has appointed veteran pharmaceutical executive John Graham CEO, Chairman and director of the company, succeeding Avner Gal, co-founder, effective March 20, 2017. The board also appointed veteran medtech executive Angela Strand as Vice Chairman, and announced the resignation of Phil Darivoff from the board. Additionally, the company announc
Feb 16, 2017 09:00 am ET
GlucoTrack® Maker Presents Scientific Data Demonstrating Reliable Accuracy and Precision
ASHDOD, Israel, Feb. 16, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it is presenting this week at the 10th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2017) in Paris, France.
Feb 06, 2017 05:16 pm ET
GlucoTrack® Maker Appoints New Chief Financial Officer
ASHDOD, Israel, Feb. 6, 2017 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today the appointment of Sami Sassoun as chief financial officer (CFO) effective February 1st, 2017. Mr. Sassoun will be succeeding Eran Hertz, who is expected to remain with the company for an undetermined period of time to assist the new CFO, Mr. Sassoun, in the transition.
Nov 11, 2016 09:00 am ET
GlucoTrack® Maker Names Two New Board Members
ASHDOD, Israel, Nov. 11, 2016 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it has appointed Philip M. Darivoff and Revan R. Schwartz to its Board of Directors, effective November 9, 2016.
Nov 10, 2016 10:21 am ET
GlucoTrack® Maker to Present Updated Scientific Data Demonstrating Increased Accuracy
ASHDOD, Israel, Nov. 10, 2016 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it is presenting today at the 16th Annual Diabetes Technology Meeting in Bethesda, Maryland.
Nov 07, 2016 09:00 am ET
GlucoTrack® Maker Announces Receipt of Final Regulatory Approval in South Korea
ASHDOD, Israel, Nov. 7, 2016 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it has received the final regulatory approval required to market and sell the GlucoTrack model DF-F in South Korea.
Jun 01, 2016 10:06 am ET
GlucoTrack® Maker Submitted Pre-Submission Supplement to US FDA
ASHDOD, Israel, June 1, 2016 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes, announced that it has set a conference call with the United States Food and Drug Administration (FDA), expected to take place in July 2016, for further discussion regarding the Company's pre-submission supplement (including clinical trial protocol) for its GlucoTrack® Model DF-F device submitted to the FDA for review on May 10, 2016. Such protocol was modified to reflect FDA remarks and discussions wi
May 31, 2016 07:49 pm ET
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
NEW YORK, May 31, 2016 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York.  The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community.  The Conference will feature presentations by CEOs and CFOs from various industr
May 31, 2016 10:13 am ET
GlucoTrack® maker to Present at Marcum and LD Micro Investor Conferences on June 2nd in New York City and June 7th in Los Angeles
ASHDOD, Israel, May 31, 2016 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that CEO Avner Gal will present at the Marcum and LD Micro investor conferences on Thursday, June 2nd at 11:30 am EDT and Tuesday, June 7th at 11:30 am PDT, respectively.
Mar 23, 2016 10:30 am ET
GlucoTrack® Maker Names Two New Board Members
ASHDOD, Israel, March 23, 2016 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it appointed Angela Strand and Leslie Seff to its Board of Directors, effective March 23, 2016. Ms. Strand will also chair the newly formed Nominating and Corporate Governance Committee of the Board.
Feb 19, 2016 09:00 am ET
GlucoTrack® Maker Receives New EU Certification
ASHDOD, Israel, Feb. 19, 2016 /PRNewswire/ -- Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, today announced that it has received an extension of its ISO 13485:2003 certificate and Annex II certification from the European Union (EU).  The ISO 13485 certification signifies that the company has met the standards required for company-wide implementation  of device quality management system(s).  The scope of the certification is design, development, manufacture and service of n

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.